Medtronic (MDT) Cost of Revenue (2014 - 2026)

Medtronic (MDT) has 13 years of Cost of Revenue data on file, last reported at $3.4 billion in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 7.98% year-over-year to $3.4 billion; the trailing twelve-month figure through Apr 2026 stood at $12.7 billion (up 9.35% YoY), and the FY2026 full-year result was $12.7 billion, up 9.36% from the prior year.
• Cost of Revenue grew to $3.4 billion in Q2 2026, from $3.3 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.4 billion in Q2 2026 to a low of $2.5 billion in Q1 2022.
• A 5-year average of $2.9 billion and a median of $2.8 billion in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue dropped 6.18% in 2022 and climbed 17.34% in 2026, its largest moves.
• Tracing MDT's Cost of Revenue over 5 years: stood at $2.5 billion in 2022, then increased by 8.92% to $2.8 billion in 2023, then advanced by 6.7% to $2.9 billion in 2024, then rose by 3.9% to $3.1 billion in 2025, then increased by 11.01% to $3.4 billion in 2026.
• Business Quant data shows MDT's Cost of Revenue at $3.4 billion in Q2 2026, $3.3 billion in Q1 2026, and $3.1 billion in Q4 2025.